SlideShare une entreprise Scribd logo
1  sur  20
Cardiac  Resynchronisation  Therapy September 2008
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure (CARE-HF) John G.F. Cleland, M.D., Jean-Claude Daubert, M.D., Erland Erdmann, M.D., Nick Freemantle, Ph.D., Daniel Gras, M.D., Lukas Kappenberger, M.D. and Luigi Tavazzi, M.D. N Engl J Med Volume 352;15:1539-1549 April 14, 2005
Background ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Methods ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Methods ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Baseline Characteristics of the Patients Cleland, J. et al. N Engl J Med 2005;352:1539-1549
Kaplan-Meier Estimates of the Time to the Primary End Point (Panel A) and the Principal Secondary Outcome (Panel B) Cleland, J. et al. N Engl J Med 2005;352:1539-1549
Study Outcomes in Analyses Stratified According to NYHA Class Cleland, J. et al. N Engl J Med 2005;352:1539-1549
Hemodynamic, Echocardiographic, and Biochemical Assessments Cleland, J. et al. N Engl J Med 2005;352:1539-1549
Discussion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cardiac Resynchronisation Therapy
Background 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Procedure 2 ,[object Object],[object Object],[object Object]
Physiological Effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Evidence ,[object Object],[object Object],[object Object]
Guidance for CRT 5 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Guidance for CRT-D 6 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Adverse Effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Further Study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
References ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Practical application of anticoagulation therapy af and vte april 12
Practical application of  anticoagulation therapy af and vte april 12Practical application of  anticoagulation therapy af and vte april 12
Practical application of anticoagulation therapy af and vte april 12
Ihsaan Peer
 
Trials and errors in cardiovascular medicine 2013
Trials and errors in cardiovascular medicine  2013Trials and errors in cardiovascular medicine  2013
Trials and errors in cardiovascular medicine 2013
Ramachandra Barik
 
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure PatientsInterventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Duke Heart
 
Dabigatran vs warfain Prior to TEE Journal Club
Dabigatran vs warfain Prior to TEE Journal ClubDabigatran vs warfain Prior to TEE Journal Club
Dabigatran vs warfain Prior to TEE Journal Club
Michael Katz
 

Tendances (17)

Anaemia in heart failure
Anaemia in heart failureAnaemia in heart failure
Anaemia in heart failure
 
Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not same
 
ueda2011 hf to mi -d.samer sayed
ueda2011 hf to mi -d.samer sayedueda2011 hf to mi -d.samer sayed
ueda2011 hf to mi -d.samer sayed
 
AHA: EMPHASIS-HF Trial
AHA: EMPHASIS-HF TrialAHA: EMPHASIS-HF Trial
AHA: EMPHASIS-HF Trial
 
Practical application of anticoagulation therapy af and vte april 12
Practical application of  anticoagulation therapy af and vte april 12Practical application of  anticoagulation therapy af and vte april 12
Practical application of anticoagulation therapy af and vte april 12
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
 
Perioperative Beta Blockers in non-cardiac surgery and POISE
Perioperative Beta Blockers in non-cardiac surgery and POISEPerioperative Beta Blockers in non-cardiac surgery and POISE
Perioperative Beta Blockers in non-cardiac surgery and POISE
 
Year in cardiology - ACS
Year in cardiology - ACSYear in cardiology - ACS
Year in cardiology - ACS
 
Trials and errors in cardiovascular medicine 2013
Trials and errors in cardiovascular medicine  2013Trials and errors in cardiovascular medicine  2013
Trials and errors in cardiovascular medicine 2013
 
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEFSimultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
Simultaneous or Rapid Sequence Initiation of Quadruple Therapy for HFrEF
 
Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...
Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...
Summary of PROVE-HF and GUIDE-IT studies by Dr. Vaibhav Yawalkar MD, DM Cardi...
 
ACC 2020 UPDATES
ACC 2020 UPDATESACC 2020 UPDATES
ACC 2020 UPDATES
 
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure PatientsInterventional and Surgical Treatment of Valve Disease in Heart Failure Patients
Interventional and Surgical Treatment of Valve Disease in Heart Failure Patients
 
Dabigatran vs warfain Prior to TEE Journal Club
Dabigatran vs warfain Prior to TEE Journal ClubDabigatran vs warfain Prior to TEE Journal Club
Dabigatran vs warfain Prior to TEE Journal Club
 
Role of ACE Inhibitors as Secondary Prevention in ACS
Role of ACE Inhibitors as Secondary Prevention in ACSRole of ACE Inhibitors as Secondary Prevention in ACS
Role of ACE Inhibitors as Secondary Prevention in ACS
 
Catecholaminergic Polymorphic VT
Catecholaminergic Polymorphic VTCatecholaminergic Polymorphic VT
Catecholaminergic Polymorphic VT
 

En vedette (8)

Cardiac Resynchronisation Therapy
Cardiac Resynchronisation TherapyCardiac Resynchronisation Therapy
Cardiac Resynchronisation Therapy
 
การวิเคราะห์ข้อมูล
การวิเคราะห์ข้อมูลการวิเคราะห์ข้อมูล
การวิเคราะห์ข้อมูล
 
Biography
BiographyBiography
Biography
 
Group 2
Group 2Group 2
Group 2
 
Mikel
MikelMikel
Mikel
 
Mina ja minu sokid
Mina ja minu sokidMina ja minu sokid
Mina ja minu sokid
 
Research Information
Research InformationResearch Information
Research Information
 
Aastaajad
AastaajadAastaajad
Aastaajad
 

Similaire à Cardiac Resynchronisation Therapy

Refractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device TherapyRefractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device Therapy
Imran Ahmed
 
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
ahvc0858
 
G Lipid Lowering In Ckd
G Lipid Lowering In CkdG Lipid Lowering In Ckd
G Lipid Lowering In Ckd
conall100
 
HF Essentials-PD- Case based discussion_Cardio.CP.Nephro.pptx
HF Essentials-PD- Case based discussion_Cardio.CP.Nephro.pptxHF Essentials-PD- Case based discussion_Cardio.CP.Nephro.pptx
HF Essentials-PD- Case based discussion_Cardio.CP.Nephro.pptx
sandeepkumarGarg4
 

Similaire à Cardiac Resynchronisation Therapy (20)

Refractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device TherapyRefractory heart failure - Diagnosis, Management, Device Therapy
Refractory heart failure - Diagnosis, Management, Device Therapy
 
Crt seminar
Crt seminarCrt seminar
Crt seminar
 
landmarck trial in HF.pdf
landmarck trial in HF.pdflandmarck trial in HF.pdf
landmarck trial in HF.pdf
 
Recent trials in heart failure
Recent trials in heart failureRecent trials in heart failure
Recent trials in heart failure
 
emphasis_HF_trial.ppt
emphasis_HF_trial.pptemphasis_HF_trial.ppt
emphasis_HF_trial.ppt
 
Acute Decompensated Heart Failure
Acute Decompensated Heart FailureAcute Decompensated Heart Failure
Acute Decompensated Heart Failure
 
Acute Decompensated Heart Failure CSI13
Acute Decompensated Heart Failure CSI13Acute Decompensated Heart Failure CSI13
Acute Decompensated Heart Failure CSI13
 
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
Guidelines and beyond new drug therapy for heart failure with reduced ejectio...
 
G Lipid Lowering In Ckd
G Lipid Lowering In CkdG Lipid Lowering In Ckd
G Lipid Lowering In Ckd
 
Clinical management of crt non responders
Clinical management of crt non respondersClinical management of crt non responders
Clinical management of crt non responders
 
Cardiac resynchronization
Cardiac resynchronizationCardiac resynchronization
Cardiac resynchronization
 
Devices
DevicesDevices
Devices
 
Risk stratification to prevent SCD in young athletes
Risk stratification to prevent SCD in young athletesRisk stratification to prevent SCD in young athletes
Risk stratification to prevent SCD in young athletes
 
Atrial fibrillation in advanced heart failure role of rate control
Atrial fibrillation in advanced heart failure role of rate controlAtrial fibrillation in advanced heart failure role of rate control
Atrial fibrillation in advanced heart failure role of rate control
 
Sudden cardiac death
Sudden cardiac deathSudden cardiac death
Sudden cardiac death
 
Optimizing heart failure management
Optimizing heart failure managementOptimizing heart failure management
Optimizing heart failure management
 
Chf
ChfChf
Chf
 
ueda2011 hypertensive diabetic patient-d.adel
ueda2011 hypertensive diabetic patient-d.adelueda2011 hypertensive diabetic patient-d.adel
ueda2011 hypertensive diabetic patient-d.adel
 
HF Essentials-PD- Case based discussion_Cardio.CP.Nephro.pptx
HF Essentials-PD- Case based discussion_Cardio.CP.Nephro.pptxHF Essentials-PD- Case based discussion_Cardio.CP.Nephro.pptx
HF Essentials-PD- Case based discussion_Cardio.CP.Nephro.pptx
 
Cardiac resynctmh
Cardiac resynctmhCardiac resynctmh
Cardiac resynctmh
 

Dernier

Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
MedicoseAcademics
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
ocean4396
 

Dernier (20)

Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and NightVIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
VIP Pune 7877925207 WhatsApp: Me All Time Serviℂe Available Day and Night
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Quality control tests of suppository ...
Quality control tests  of suppository ...Quality control tests  of suppository ...
Quality control tests of suppository ...
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
Results For Love Spell Is Guaranteed In 1 Day +27834335081 [BACK LOST LOVE SP...
 
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
CAS 110-63-4 BDO Liquid 1,4-Butanediol 1 4 BDO Warehouse Supply For Excellent...
 
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
PYODERMA, IMPETIGO, FOLLICULITIS, FURUNCLES, CARBUNCLES.pdf
PYODERMA, IMPETIGO, FOLLICULITIS, FURUNCLES, CARBUNCLES.pdfPYODERMA, IMPETIGO, FOLLICULITIS, FURUNCLES, CARBUNCLES.pdf
PYODERMA, IMPETIGO, FOLLICULITIS, FURUNCLES, CARBUNCLES.pdf
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
 
Tissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood BankingTissue Banking and Umbilical Cord Blood Banking
Tissue Banking and Umbilical Cord Blood Banking
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
Premium ℂall Girls In Mumbai👉 Dail ℂALL ME: 📞9833325238 📲 ℂall Richa VIP ℂall...
 

Cardiac Resynchronisation Therapy

  • 1. Cardiac Resynchronisation Therapy September 2008
  • 2. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure (CARE-HF) John G.F. Cleland, M.D., Jean-Claude Daubert, M.D., Erland Erdmann, M.D., Nick Freemantle, Ph.D., Daniel Gras, M.D., Lukas Kappenberger, M.D. and Luigi Tavazzi, M.D. N Engl J Med Volume 352;15:1539-1549 April 14, 2005
  • 3.
  • 4.
  • 5.
  • 6. Baseline Characteristics of the Patients Cleland, J. et al. N Engl J Med 2005;352:1539-1549
  • 7. Kaplan-Meier Estimates of the Time to the Primary End Point (Panel A) and the Principal Secondary Outcome (Panel B) Cleland, J. et al. N Engl J Med 2005;352:1539-1549
  • 8. Study Outcomes in Analyses Stratified According to NYHA Class Cleland, J. et al. N Engl J Med 2005;352:1539-1549
  • 9. Hemodynamic, Echocardiographic, and Biochemical Assessments Cleland, J. et al. N Engl J Med 2005;352:1539-1549
  • 10.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.